Steven D. Rubin, Director at Cocrystal Pharma, Inc. (COCP), bought 39,216 shares at $0.51 ($20K) on 2016-03-15, disclosed to the SEC on 2016-03-18.
Open-market purchase of $20k COCP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| RDVT | SELL | 2025-03-21 | $389K | — | Filing → |
| OPK | BUY | 2024-01-05 | $9K | — | Filing → |
| OPK | BUY | 2023-11-13 | $13K | — | Filing → |